Tirzepatide, a recently approved medication, is sparking significant interest in the healthcare community as a viable treatment for both managing blood sugar and weight loss . This dual-action drug works by stimulating two different receptors, GLP-1 and GIP, leading to improved glycemic management and notable slimming in clinical trials . While pre